Ray Dalio's EMN Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 102,071 shares of Eastman Chemical Company (EMN) worth $6.52 M, representing 0.02% of the portfolio. First purchased in 2013-Q3, this long-term strategic position has been held for 42 quarters.
Based on 13F filings since 2013, Ray Dalio has maintained a long-term strategic position in EMN, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2018, adding 624,555 shares. Largest reduction occurred in Q2 2019, reducing 301,843 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Eastman Chemical Company (EMN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eastman Chemical Company (EMN) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +102,071 | New Buy | 102,071 | $63.83 |
| Q3 2025 | -9,779 | Sold Out | 0 | $0.00 |
| Q2 2025 | -120,926 | Reduce 92.52% | 9,779 | $74.66 |
| Q1 2025 | +22,115 | Add 20.37% | 130,705 | $88.11 |
| Q4 2024 | -9,655 | Reduce 8.17% | 108,590 | $91.32 |
| Q3 2024 | +28,328 | Add 31.50% | 118,245 | $111.95 |
| Q2 2024 | -17,638 | Reduce 16.40% | 89,917 | $97.97 |
| Q1 2024 | +12,329 | Add 12.95% | 107,555 | $100.22 |
| Q4 2023 | +55,460 | Add 139.47% | 95,226 | $89.82 |
| Q3 2023 | +20,596 | Add 107.44% | 39,766 | $76.72 |
| Q2 2023 | +19,170 | New Buy | 19,170 | $83.72 |
| Q3 2022 | -122,413 | Sold Out | 0 | $0.00 |
| Q2 2022 | +43,907 | Add 55.93% | 122,413 | $89.77 |
| Q1 2022 | +78,506 | New Buy | 78,506 | $112.06 |
| Q3 2021 | -39,780 | Sold Out | 0 | $0.00 |
| Q2 2021 | +39,780 | New Buy | 39,780 | $116.74 |
| Q1 2021 | -12,232 | Sold Out | 0 | $0.00 |
| Q4 2020 | -1,285 | Reduce 9.51% | 12,232 | $100.31 |
| Q3 2020 | +10,420 | Add 336.45% | 13,517 | $78.12 |
| Q2 2020 | +3,097 | New Buy | 3,097 | $69.74 |
| Q1 2020 | -7,272 | Sold Out | 0 | $0.00 |
| Q4 2019 | -139,649 | Reduce 95.05% | 7,272 | $79.21 |
| Q3 2019 | -151,260 | Reduce 50.73% | 146,921 | $73.83 |
| Q2 2019 | -301,843 | Reduce 50.31% | 298,181 | $77.83 |
| Q1 2019 | -24,531 | Reduce 3.93% | 600,024 | $75.88 |
| Q4 2018 | +624,555 | New Buy | 624,555 | $73.11 |
| Q3 2017 | -33,231 | Sold Out | 0 | $0.00 |
| Q2 2017 | +33,231 | New Buy | 33,231 | $83.99 |
| Q4 2016 | -53,800 | Sold Out | 0 | $0.00 |
| Q3 2016 | -85,000 | Reduce 61.24% | 53,800 | $67.68 |
| Q2 2016 | +73,283 | Add 111.85% | 138,800 | $67.90 |
| Q1 2016 | -72,052 | Reduce 52.38% | 65,517 | $72.23 |
| Q4 2015 | -243,469 | Reduce 63.90% | 137,569 | $67.51 |
| Q3 2015 | +335,500 | Add 736.75% | 381,038 | $64.72 |
| Q2 2015 | -181,000 | Reduce 79.90% | 45,538 | $81.82 |
| Q1 2015 | -75,248 | Reduce 24.93% | 226,538 | $69.26 |
| Q4 2014 | +243,659 | Add 419.18% | 301,786 | $75.86 |
| Q3 2014 | +12,000 | Add 26.02% | 58,127 | $80.89 |
| Q2 2014 | +34,140 | Add 284.81% | 46,127 | $87.35 |
| Q1 2014 | -36,400 | Reduce 75.23% | 11,987 | $86.18 |
| Q4 2013 | -5,900 | Reduce 10.87% | 48,387 | $80.70 |
| Q3 2013 | +54,287 | New Buy | 54,287 | $77.90 |
Ray Dalio's Eastman Chemical Company Investment FAQs
Ray Dalio first purchased Eastman Chemical Company (EMN) in Q3 2013, acquiring 54,287 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Eastman Chemical Company (EMN) for 42 quarters since Q3 2013.
Ray Dalio's largest addition to Eastman Chemical Company (EMN) was in Q4 2018, adding 624,555 shares worth $45.66 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 102,071 shares of Eastman Chemical Company (EMN), valued at approximately $6.52 M.
As of the Q4 2025 filing, Eastman Chemical Company (EMN) represents approximately 0.02% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Eastman Chemical Company (EMN) was 624,555 shares, as reported at the end of Q4 2018.